Cargando…
Current Evidence for the Prevention of Endophthalmitis in Anti-VEGF Intravitreal Injections
Intravitreal injection of a therapeutic substance is the most common procedure performed in ophthalmology. It has a low incidence of serious complications but is associated with a small chance of endophthalmitis. Although the rate of endophthalmitis is between 0.019% and 0.09%, the associated visual...
Autores principales: | Lau, P. ET., Jenkins, K. S., Layton, C. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098904/ https://www.ncbi.nlm.nih.gov/pubmed/30174946 http://dx.doi.org/10.1155/2018/8567912 |
Ejemplares similares
-
Endophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injection: a comprehensive review
por: Merani, Rohan, et al.
Publicado: (2015) -
Global reported endophthalmitis risk following intravitreal injections of anti-VEGF: a literature review and analysis
por: Sigford, Douglas K, et al.
Publicado: (2015) -
Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibiotics
por: Morioka, Masakazu, et al.
Publicado: (2020) -
Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series
por: Bergamo, Vinicius Campos, et al.
Publicado: (2023) -
How to prevent endophthalmitis after intravitreal injections
por: Goldberg, Roger A
Publicado: (2015)